1. Home
  2. EDD vs CADL Comparison

EDD vs CADL Comparison

Compare EDD & CADL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

EDD

Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

HOLD

Current Price

$5.11

Market Cap

397.7M

Sector

Finance

ML Signal

HOLD

Logo Candel Therapeutics Inc.

CADL

Candel Therapeutics Inc.

HOLD

Current Price

$4.49

Market Cap

357.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
EDD
CADL
Founded
2007
1999
Country
United States
United States
Employees
N/A
N/A
Industry
Finance Companies
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
397.7M
357.4M
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
EDD
CADL
Price
$5.11
$4.49
Analyst Decision
Strong Buy
Analyst Count
0
7
Target Price
N/A
$19.71
AVG Volume (30 Days)
522.8K
1.2M
Earning Date
01-01-0001
03-12-2026
Dividend Yield
7.52%
N/A
EPS Growth
N/A
58.62
EPS
N/A
N/A
Revenue
N/A
$125,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.28
$4.25
52 Week High
$6.18
$7.24

Technical Indicators

Market Signals
Indicator
EDD
CADL
Relative Strength Index (RSI) 25.26 36.24
Support Level $4.98 N/A
Resistance Level $5.68 $6.13
Average True Range (ATR) 0.10 0.25
MACD -0.03 -0.01
Stochastic Oscillator 8.62 4.37

Price Performance

Historical Comparison
EDD
CADL

About EDD Morgan Stanley Emerging Markets Domestic Debt Fund Inc.

Morgan Stanley Emerging Markets Domestic Debt Fund Inc is a closed-end management investment company. The company's primary investment objective is to seek a high level of current income, with a secondary investment objective of long-term capital appreciation. It seeks to achieve investment objectives by investing, under normal circumstances, at least 80% of its managed assets in emerging markets domestic debt. The fund's portfolio includes sovereign, quasi-sovereign, corporate bonds in emerging markets.

About CADL Candel Therapeutics Inc.

Candel Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing off-the-shelf viral immunotherapies that elicit an individualized, systemic anti-tumor immune response to help patients fight cancer. The immune cells induced by these viral immunotherapies are believed to target patients' specific tumor antigens, potentially improving responses in immunologically hot tumors while at the same time infiltrating the tumor microenvironment, transforming non-inflamed cold tumors with limited immune response into hot tumors. The company has established two clinical off-the-shelf viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.

Share on Social Networks: